Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder.
Expert Opinion on Emerging Drugs September 1, 2024 Sophie Köhne, Thomas Hillemacher, Alexander Glahn et al. 16 citations
Alcohol Use Disorder (AUD) poses an ongoing significant global health burden. AUD is highly prevalent and affects not only the individuals with AUD, but also their communities and society at large. Even though pharmacotherapy is an integral part of AUD treatment, the few available substances show limited efficacy and limited clinical impact. Thus, there is a need for new innovative...